The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
8-(dibenzo[b,d]thiophen-1-yl)-2-morpholino-4H-chromen-4-one ID: ALA5287725
Max Phase: Preclinical
Molecular Formula: C25H19NO3S
Molecular Weight: 413.50
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=c1cc(N2CCOCC2)oc2c(-c3cccc4sc5ccccc5c34)cccc12
Standard InChI: InChI=1S/C25H19NO3S/c27-20-15-23(26-11-13-28-14-12-26)29-25-17(7-3-8-18(20)25)16-6-4-10-22-24(16)19-5-1-2-9-21(19)30-22/h1-10,15H,11-14H2
Standard InChI Key: LSUVJEUFZJPDTK-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 35 0 0 0 0 0 0 0 0999 V2000
-1.5699 -0.4114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8553 0.0008 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.1434 -0.4109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1434 -1.2362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8536 -1.6480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5699 -1.2399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5692 -0.0001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2841 -0.4126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2859 -1.2337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5743 -1.6504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5692 0.8249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1453 1.2378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1446 2.0605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5702 2.4732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2820 2.0640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2868 1.2393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2846 0.0011 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.9994 -0.4112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7115 0.0007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7115 0.8261 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.0012 1.2381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2846 0.8298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8536 -2.4732 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.0726 0.9890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0649 2.3234 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.5535 1.6590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3715 1.5771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7115 0.8257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2345 0.1580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4140 0.2345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 2 0
6 5 1 0
3 7 1 0
8 7 2 0
9 8 1 0
10 9 2 0
4 10 1 0
11 7 1 0
12 11 2 0
13 12 1 0
14 13 2 0
15 14 1 0
11 16 1 0
16 15 2 0
17 1 1 0
18 17 1 0
19 18 1 0
20 19 1 0
21 20 1 0
17 22 1 0
22 21 1 0
5 23 2 0
16 24 1 0
15 25 1 0
25 26 1 0
26 24 2 0
26 27 1 0
28 27 2 0
29 28 1 0
30 29 2 0
24 30 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 413.50Molecular Weight (Monoisotopic): 413.1086AlogP: 5.66#Rotatable Bonds: 2Polar Surface Area: 42.68Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 5.38CX LogD: 5.38Aromatic Rings: 5Heavy Atoms: 30QED Weighted: 0.37Np Likeness Score: -0.57
References 1. Carlino L, Rastelli G.. (2016) Dual Kinase-Bromodomain Inhibitors in Anticancer Drug Discovery: A Structural and Pharmacological Perspective., 59 (20): [PMID:27559828 ] [10.1021/acs.jmedchem.6b00438 ]